share

5,6,8,13-Tetrahydro-2,3-Dimethoxy-9,10-(Methylenedioxy)-13Ah-Dibenzo[A,G]Quinolizine CAS NO 522-96-3


Unit Price:

CAS No.:522-96-3

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

5,6,8,13-Tetrahydro-2,3-Dimethoxy-9,10-(Methylenedioxy)-13Ah-Dibenzo[A,G]Quinolizine is a complex, multi-cyclic alkaloid derivative of significant interest in advanced organic synthesis and pharmaceutical research. This compound serves as a crucial intermediate or reference standard for the development of novel bioactive molecules, particularly those targeting neurological pathways. It is primarily utilized by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers engaged in the synthesis of complex heterocyclic compounds.

Application

  • Pharmaceutical Intermediate: Key building block for the synthesis of complex alkaloids and potential drug candidates in neurological and cardiovascular research.
  • Chemical Reference Standard: Used as a high-purity standard in analytical chemistry for method development, validation, and quality control in pharmaceutical analysis.
  • Academic & Industrial Research: Serves as a substrate or model compound in studies of organic reaction mechanisms, catalysis, and heterocyclic chemistry.
  • Biochemical Research: Investigated for its interaction with biological receptors and enzymes due to its complex polycyclic structure.
  • Fine Chemical Synthesis: Employed in the multi-step synthesis of specialized, high-value compounds for various research and development purposes.

Basic Information

Product Name 5,6,8,13-Tetrahydro-2,3-Dimethoxy-9,10-(Methylenedioxy)-13Ah-Dibenzo[A,G]Quinolizine
CAS No. 522-96-3
Molecular Formula C₂₁H₂₁NO₅
Molecular Weight 367.40 g/mol
Synonyms 13ah-Dibenzo[a,g]quinolizine-2,3-dimethoxy-9,10-methylenedioxy-5,6,8,13-tetrahydro; 2,3-Dimethoxy-9,10-methylenedioxy-5,6,8,13-tetrahydro-13ah-dibenzo[a,g]quinolizine; NSC 51046; Tetrahydroberberine derivative; 9,10-Methylenedioxy-2,3-dimethoxy-13ah-dibenzo[a,g]quinolizine
EINECS Contact for details

Quality Control

Our production of 5,6,8,13-Tetrahydro-2,3-Dimethoxy-9,10-(Methylenedioxy)-13Ah-Dibenzo[A,G]Quinolizine adheres to stringent internal quality protocols to ensure batch-to-batch consistency and high purity. Each lot is characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment to support your research and quality assurance requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider the use of desiccants.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 97.0%
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.5%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.